Gray; Nathanael S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gray; Nathanael S..The latest application filed is for "uses of salt-inducible kinase (sik) inhibitors for treating osteoporosis".

Company Profile

113.94.200

Gray; Nathanael S. - Stanford CA
Gray; Nathanael S. - Boston MA
Gray; Nathanael S. - Jamaica Plain MA
Gray; Nathanael S. - Boton MA
Gray; Nathanael S - San Diego CA
GRAY; Nathanael S. - San Diego CA
Gray; Nathanael S. - La Jolla CA
Gray; Nathanael S. - Berkeley CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis App 20220305016 - Wein; Marc ; et al.	2022-09-29
Compounds for the degradation of STK4 and treatment of hematologic malignancies Grant 11,447,467 - Buhrlage , et al. September 20, 2	2022-09-20
Degraders Of Cyclin-dependent Kinase 7 (cdk7) And Uses Thereof App 20220280649 - Gray; Nathanael S. ; et al.	2022-09-08
Inhibitors Of Cyclin-dependent Kinase 7 And Uses Thereof App 20220281874 - Zhang; Tinghu ; et al.	2022-09-08
Small Molecule Inhibitors Of Src Tyrosine Kinase App 20220267294 - Gray; Nathanael S. ; et al.	2022-08-25
Inhibitors Of Cyclin-dependent Kinases App 20220242865 - Gray; Nathanael S. ; et al.	2022-08-04
Allosteric Egfr Inhibitors And Methods Of Use Thereof App 20220233545 - Gray; Nathanael S. ; et al.	2022-07-28
Degraders Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20220227734 - Che; Jianwei ; et al.	2022-07-21
Inhibitors Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20220213067 - Gray; Nathanael S. ; et al.	2022-07-07
Pyrrolopyrimidine Inhibitors Of Wild-type And Mutant Forms Of Lrrk2 App 20220204515 - Gray; Nathanael S. ; et al.	2022-06-30
Taire Family Kinase Inhibitors And Uses Thereof App 20220169631 - Gray; Nathanael S. ; et al.	2022-06-02
Inhibitors Of C-jun-n-terminal Kinase (jnk) App 20220153730 - Gray; Nathanael S. ; et al.	2022-05-19
Inhibitors of cyclin-dependent kinases Grant 11,325,910 - Gray , et al. May 10, 2	2022-05-10
Uses Of Pyrimidopyrimidinones As Sik Inhibitors App 20220133736 - Fisher; David E. ; et al.	2022-05-05
Small Molecule Myristate Inhibitors Of Bcr-abl And Methods Of Use App 20220135573 - GRAY; Nathanael S. ; et al.	2022-05-05
Benzimidazole Derivatives And Aza-benzimidazole Derivatives As Janus Kinase 2 Inhibitors And Uses Thereof App 20220127246 - Gray; Nathanael S. ; et al.	2022-04-28
Benzothiazole Derivatives And 7-aza-benzothiazole Derivatives As Janus Kinase 2 Inhibitors And Uses Thereof App 20220127284 - Gray; Nathanael S. ; et al.	2022-04-28
Imidazopyridine Derivatives And Aza-imidazopyridine Derivatives As Janus Kinase 2 Inhibitors And Uses Thereof App 20220127260 - Gray; Nathanael S. ; et al.	2022-04-28
Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof Grant 11,306,070 - Gray , et al. April 19, 2	2022-04-19
Macrocyclic Inhibitors Of Dyrk1a App 20220112201 - Gray; Nathanael S. ; et al.	2022-04-14
Degradation Of Cyclin-dependent Kinase 8 (cdk8) By Conjugation Of Cdk8 Inhibitors With E3 Ligase Ligand And Methods Of Use App 20220112191 - Gray; Nathanael S. ; et al.	2022-04-14
Inhibitors Of Egfr And/or Her2 And Methods Of Use App 20220106310 - Hatcher; John M. ; et al.	2022-04-07
Uses of pyrimidopyrimidinones as SIK inhibitors Grant 11,285,158 - Fisher , et al. March 29, 2	2022-03-29
SMALL MOLECULE DEGRADERS OF FKBP12 VIA RECRUITMENT OF VON HIPPEL-LINDAU E3 UBIQUITIN LIGASE (VHL) E3 UBIQUITIN LIGASE, AND USES IN dTAG SYSTEMS App 20220089589 - Gray; Nathanael S. ; et al.	2022-03-24
Inhibitors Of Cyclin-dependent Kinase 7 And Uses Thereof App 20220089611 - Gray; Nathanael S. ; et al.	2022-03-24
NEK inhibitors and methods of use Grant 11,279,707 - Gray , et al. March 22, 2	2022-03-22
Pyrazolopyridine Inhibitors Of C-jun-n-terminal Kinases And Uses Thereof App 20220073512 - Gray; Nathanael S. ; et al.	2022-03-10
Compositions And Methods Of Treating Cancers By Administering A Phenothiazine-related Drug That Activates Protein Phosphatase 2a (pp2a) With Reduced Inhibitory Activity Targeted To The Dopamine D2 Receptor And Accompanying Toxicity App 20220062291 - Look; Alfred T. ; et al.	2022-03-03
Inhibitors Of Cyclin-dependent Kinases App 20220055998 - Gray; Nathanael S. ; et al.	2022-02-24
Small molecule myristate inhibitors of Bcr-abl and methods of use Grant 11,254,682 - Gray , et al. February 22, 2	2022-02-22
Degraders Of Wee1 Kinase App 20220047709 - Gray; Nathanael S. ; et al.	2022-02-17
Inhibitors of MALT1 and uses thereof Grant 11,248,007 - Gray , et al. February 15, 2	2022-02-15
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Grant 11,247,991 - Gray , et al. February 15, 2	2022-02-15
Degradation Of Fak Or Fak And Alk By Conjugation Of Fak And Alk Inhibitors With E3 Ligase Ligands And Methods Of Use App 20220040317 - Gray; Nathanael S. ; et al.	2022-02-10
Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis Grant 11,241,435 - Wein , et al. February 8, 2	2022-02-08
Macrocyclic Inhibitors Of Alk, Trka, Trkb, And Ros1 App 20220033402 - Gray; Nathanael S. ; et al.	2022-02-03
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20220024929 - Gray; Nathanael S. ; et al.	2022-01-27
Bifunctional Molecules For Degradation Of Egfr And Methods Of Use App 20220017510 - GRAY; NATHANAEL S. ; et al.	2022-01-20
Inhibitors of EGFR and/or HER2 and methods of use Grant 11,186,574 - Hatcher , et al. November 30, 2	2021-11-30
Degraders Of Wild-type And Mutant Forms Of Lrrk2 App 20210361774 - Gray; Nathanael S. ; et al.	2021-11-25
Cyano Quinoline Amide Compounds As Her2 Inhibitors And Methods Of Use App 20210355119 - GRAY; NATHANAEL S. ; et al.	2021-11-18
Azaindole Inhibitors Of Wild-type And Mutant Forms Of Lrrk2 App 20210347772 - Gray; Nathanael S. ; et al.	2021-11-11
Inhibitors Of Egfr And Methods Of Use Thereof App 20210346395 - GRAY; NATHANAEL S. ; et al.	2021-11-11
Degraders Of Hepatitis C Virus Ns3/4a Protein App 20210338825 - Gray; Nathanael S. ; et al.	2021-11-04
Degradation Of Cyclin-dependent Kinase 4/6 (cdk4/6) By Conjugation Of Cdk4/6 Inhibitors With E3 Ligase Ligand And Methods Of Use App 20210340140 - GRAY; NATHANAEL S. ; et al.	2021-11-04
Substituted 6,11-dihydro-5h-benzo[b]carbazoles As Inhibitors Of Alk And Srpk App 20210340102 - Hatcher; John ; et al.	2021-11-04
Modulators Of Pin1 Activity And Uses Thereof App 20210332024 - LONDON; Nir ; et al.	2021-10-28
Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders Grant 11,155,556 - Gray , et al. October 26, 2	2021-10-26
Inhibitors Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20210317105 - Gray; Nathanael S. ; et al.	2021-10-14
4,6-pyrimidinylene Derivatives And Uses Thereof App 20210315894 - Gray; Nathanael S. ; et al.	2021-10-14
Inhibitors of cyclin-dependent kinases Grant 11,142,507 - Gray , et al. October 12, 2	2021-10-12
Inhibitors Of C-jun-n-terminal Kinase (jnk) App 20210300911 - Gray; Nathanael S. ; et al.	2021-09-30
Taire Family Kinase Inhibitors And Uses Thereof App 20210292299 - Gray; Nathanael S. ; et al.	2021-09-23
Degraders That Target Proteins Via Keap1 App 20210276996 - Gray; Nathanael S. ; et al.	2021-09-09
Inhibitors Of Cyclin-dependent Kinases App 20210261551 - Gray; Nathanael S. ; et al.	2021-08-26
Irak Degraders And Uses Thereof App 20210230144 - Gray; Nathanael S. ; et al.	2021-07-29
Compounds For Treating Dengue Virus Infections And Other Infections App 20210230101 - Yang; Priscilla L. ; et al.	2021-07-29
Uses Of Kinase Inhibitors For Inducing And Maintaining Pluripotency App 20210230538 - Theunissen; Thorold W. ; et al.	2021-07-29
Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK Grant 11,066,363 - Hatcher , et al. July 20, 2	2021-07-20
Pyrimido-diazepinone kinase scaffold compounds and methods of treating DCLK1/2-mediated disorders Grant 11,028,089 - Ferguson , et al. June 8, 2	2021-06-08
Compounds For Tau Protein Degradation App 20210154184 - Gray; Nathanael S. ; et al.	2021-05-27
Imidazolyl Kinase Inhibitors And Uses Thereof App 20210147388 - Gray; Nathanael S. ; et al.	2021-05-20
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20210147425 - Gray; Nathanael S. ; et al.	2021-05-20
Heterobifunctional Compounds With Improved Specificity App 20210130368 - NOWAK; Radoslaw P. ; et al.	2021-05-06
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20210115051 - Gray; Nathanael S. ; et al.	2021-04-22
Lrrk2 Inhibitors And Methods Of Making And Using The Same App 20210115055 - Gray; Nathanael S. ; et al.	2021-04-22
Inhibitors of c-Jun-N-terminal kinase (JNK) Grant 10,981,903 - Gray , et al. April 20, 2	2021-04-20
Imidazolyl kinase inhibitors and uses thereof Grant 10,975,058 - Gray , et al. April 13, 2	2021-04-13
Inhibitors of interleukin-1 receptor-associated kinases and uses thereof Grant 10,975,055 - Gray , et al. April 13, 2	2021-04-13
Degradation Of Bruton's Tyrosine Kinase (btk) By Conjugation Of Btk Inhibitors With E3 Ligase Ligand And Methods Of Use App 20210100908 - Gray; Nathanael S. ; et al.	2021-04-08
Inhibitors Of Egfr And Methods Of Use Thereof App 20210094913 - GRAY; Nathanael S. ; et al.	2021-04-01
Pharmaceutical Combinations Of Egfr Inhibitors And Methods Of Use Thereof App 20210085688 - GRAY; NATHANAEL S. ; et al.	2021-03-25
Bicyclic urea kinase inhibitors and uses thereof Grant 10,954,242 - Gray , et al. March 23, 2	2021-03-23
Novel Pyrimidines As Egfr Inhibitors And Methods Of Treating Disorders App 20210078977 - GRAY; Nathanael S. ; et al.	2021-03-18
Pharmaceutical Combinations Of Egfr Inhibitors And Methods Of Use Thereof App 20210077469 - GRAY; NATHANAEL S. ; et al.	2021-03-18
Cyclin-dependent Kinase Degraders And Methods Of Use App 20210054020 - Gray; Nathanael S. ; et al.	2021-02-25
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use Grant 10,925,868 - Gray , et al. February 23, 2	2021-02-23
Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use Grant 10,925,967 - Gray , et al. February 23, 2	2021-02-23
Inhibitors Of Egfr And Methods Of Use Thereof App 20210040088 - GRAY; NATHANAEL S. ; et al.	2021-02-11
Degradation Of Cyclin-dependent Kinase 8 (cdk8) By Conjugation Of Cdk8 Inhibitors With E3 Ligase Ligand And Methods Of Use App 20210040093 - GRAY; Nathanael S. ; et al.	2021-02-11
LRRK2 inhibitors and methods of making and using the same Grant 10,913,744 - Gray , et al. February 9, 2	2021-02-09
Degradation Of Bruton's Tyrosine Kinase (btk) By Conjugation Of Btk Inhibitors With E3 Ligase Ligand And Methods Of Use App 20210030832 - Gray; Nathanael S. ; et al.	2021-02-04
Kinase inhibitors for the treatment of disease Grant 10,906,878 - Gray , et al. February 2, 2	2021-02-02
Small Molecule Degraders That Recruit Dcaf15 App 20210002295 - Gray; Nathanael S. ; et al.	2021-01-07
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,870,651 - Gray , et al. December 22, 2	2020-12-22
Pyrimidines as EGFR inhibitors and methods of treating disorders Grant 10,870,636 - Gray , et al. December 22, 2	2020-12-22
Inhibitors Of Egfr And Methods Of Use Thereof App 20200390783 - GRAY; NATHANAEL S. ; et al.	2020-12-17
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Grant 10,865,205 - Gray , et al. December 15, 2	2020-12-15
Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use Grant 10,865,204 - Gray , et al. December 15, 2	2020-12-15
Inhibitors Of Malt1 And Uses Thereof App 20200385405 - Gray; Nathanael S. ; et al.	2020-12-10
Degraders Of Egfr And Methods Of Use Thereof App 20200377477 - GRAY; NATHANAEL S. ; et al.	2020-12-03
Pharmaceutical Combinations Of Egfr Inhibitors And Methods Of Use Thereof App 20200375999 - GRAY; NATHANAEL S. ; et al.	2020-12-03
Degraders Of Egfr And Methods Of Use Thereof App 20200377501 - GRAY; NATHANAEL S. ; et al.	2020-12-03
Cyclin-dependent Kinase Inhibitors And Methods Of Use App 20200369715 - Gray; Nathanael S. ; et al.	2020-11-26
Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use Grant 10,842,878 - Gray , et al. November 24, 2	2020-11-24
Thiazolyl-containing compounds for treating proliferative diseases Grant 10,844,077 - Gray , et al. November 24, 2	2020-11-24
Compounds For Treating Dengue Virus Infection And Other Viral Infections App 20200360381 - Yang; Priscilla L. ; et al.	2020-11-19
Nek Inhibitors And Methods Of Use App 20200361948 - GRAY; NATHANAEL S. ; et al.	2020-11-19
Inhibitors Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20200361906 - Gray; Nathanael S. ; et al.	2020-11-19
Inhibitors of EGFR and methods of use thereof Grant 10,836,722 - Gray , et al. November 17, 2	2020-11-17
Small Molecule Myristate Inhibitors Of Bcr-abl And Methods Of Use App 20200347068 - GRAY; Nathanael S. ; et al.	2020-11-05
4,6-pyrimidinylene Derivatives And Uses Thereof App 20200338075 - Gray; Nathanael S. ; et al.	2020-10-29
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20200338087 - Shamji; Alykhan ; et al.	2020-10-29
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors App 20200338074 - Hammerman; Peter ; et al.	2020-10-29
Compounds For The Degradation Of Stk4 And Treatment Of Hematologic Malignancies App 20200331889 - Buhrlage; Sara ; et al.	2020-10-22
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20200317675 - GRAY; Nathanael S. ; et al.	2020-10-08
Uses of diazepane derivatives Grant 10,793,571 - Bradner , et al. October 6, 2	2020-10-06
Pyrimido-diazepinone compounds and methods of treating disorders Grant 10,787,461 - Gray , et al. September 29, 2	2020-09-29
Inhibitors Of Interleukin-1 Receptor-associated Kinases And Uses Thereof App 20200299257 - Gray; Nathanael S. ; et al.	2020-09-24
Type Ii Raf Kinase Inhibitors App 20200297721 - Gray; Nathanael S. ; et al.	2020-09-24
Sulfonamide Derivatives For Protein Degradation App 20200290964 - Gray; Nathanael S. ; et al.	2020-09-17
Inhibitors Of Cyclin-dependent Kinases App 20200277292 - Gray; Nathanael S. ; et al.	2020-09-03
Uses Of Pyrimidopyrimidinones As Sik Inhibitors App 20200253981 - Kind Code	2020-08-13
6,11-dihydro-5h-benzo[b]carbazole Inhibitors Of Alk And Srpk And Methods Of Use App 20200223798 - HATCHER; John ; et al.	2020-07-16
STK4 inhibitors for treatment of hematologic malignancies Grant 10,710,978 - Gray , et al.	2020-07-14
MALT1 inhibitors and uses thereof Grant 10,711,036 - Gray , et al.	2020-07-14
Bifunctional Molecules For Her3 Degradation And Methods Of Use App 20200216454 - GRAY; Nathanael S. ; et al.	2020-07-09
Combination therapy of transcription inhibitors and kinase inhibitors Grant 10,702,527 - Hammerman , et al.	2020-07-07
4,6-pyrimidinylene derivatives and uses thereof Grant 10,695,346 - Gray , et al.	2020-06-30
Inhibitors Of Egfr And/or Her2 And Methods Of Use App 20200199121 - HATCHER; JOHN M. ; et al.	2020-06-25
Compounds for MALT1 degredation Grant 10,689,366 - Melnick , et al.	2020-06-23
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis App 20200179387 - Wein; Marc ; et al.	2020-06-11
Inhibitors Of Cyclin-dependent Kinases App 20200172499 - Gray; Nathanael S. ; et al.	2020-06-04
Thiazolyl-containing Compounds For Treating Proliferative Diseases App 20200165267 - Gray; Nathanael S. ; et al.	2020-05-28
Methods to treat lymphoplasmacytic lymphoma Grant 10,633,348 - Treon , et al.	2020-04-28
Methods to treat lymphoplasmacytic lymphoma Grant 10,597,387 - Treon , et al.	2020-03-24
Inhibitors Of C-jun-n-terminal Kinase (jnk) App 20200087295 - Gray; Nathanael S. ; et al.	2020-03-19
Pyrimido-diazepinone Compounds And Methods Of Treating Disorders App 20200071340 - Gray; Nathanael S. ; et al.	2020-03-05
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 10,570,154 - Gray , et al. Feb	2020-02-25
Inhibitors of cyclin-dependent kinases Grant 10,550,121 - Gray , et al. Fe	2020-02-04
Pyrimidines as EGFR inhibitors and methods of treating disorders Grant 10,550,112 - Gray , et al. Fe	2020-02-04
Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use Grant 10,532,103 - Gray , et al. Ja	2020-01-14
HCK as a therapeutic target in MYD88 mutated diseases Grant 10,525,060 - Treon , et al. J	2020-01-07
Inhibitors Of Egfr And Methods Of Use Thereof App 20200002279 - GRAY; Nathanael S. ; et al.	2020-01-02
Malt1 Inhibitors And Uses Thereof App 20190389904 - Gray; Nathanael S. ; et al.	2019-12-26
Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK Grant 10,508,082 - Hatcher , et al. Dec	2019-12-17
Degradation Of Protein Kinases By Conjugation Of Protein Kinase Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190374528 - GRAY; Nathanael S. ; et al.	2019-12-12
Imidazolyl Kinase Inhibitors And Uses Thereof App 20190367487 - Gray; Nathanael S. ; et al.	2019-12-05
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20190343842 - Shamji; Alykhan ; et al.	2019-11-14
Thiazolyl-containing compounds for treating proliferative diseases Grant 10,464,949 - Gray , et al. No	2019-11-05
Macrocyclic kinase inhibitors and uses thereof Grant 10,457,691 - Gray , et al. Oc	2019-10-29
Pyrimido-diazepinone compounds and methods of treating disorders Grant 10,457,692 - Gray , et al. Oc	2019-10-29
Compounds and methods for treating cancer Grant 10,450,281 - D'Andrea , et al. Oc	2019-10-22
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20190315752 - GRAY; Nathanael S. ; et al.	2019-10-17
Inhibitors Of Cyclin-dependent Kinases App 20190315747 - Gray; Nathanael S. ; et al.	2019-10-17
Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Dclk1/2-mediated Disorders App 20190315753 - Ferguson; Fleur M. ; et al.	2019-10-17
Host Targeted Inhibitors Of Dengue Virus And Other Viruses App 20190292178 - Gray; Nathanael S. ; et al.	2019-09-26
Inhibitors Of Interleukin-1 Receptor-associated Kinases And Uses Thereof App 20190276426 - Gray; Nathanael S. ; et al.	2019-09-12
Degradation Of Bruton's Tyrosine Kinase (btk) By Conjugation Of Btk Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190262458 - GRAY; Nathanael S. ; et al.	2019-08-29
Compounds For Malt1 Degradation App 20190263785 - Melnick; Ari M. ; et al.	2019-08-29
Degradation Of Bruton's Tyrosine Kinase (btk) By Conjugation Of Btk Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190262459 - GRAY; Nathanael S. ; et al.	2019-08-29
Kinase Inhibitors For The Treatment Of Disease App 20190256475 - GRAY; Nathanael S. ; et al.	2019-08-22
Inhibitors of EGFR and methods of use thereof Grant 10,385,019 - Gray , et al. A	2019-08-20
Inhibitors Of C-jun-n-terminal Kinase (jnk) App 20190248778 - Gray; Nathanael S. ; et al.	2019-08-15
Fused bicyclic pyrimidine derivatives and uses thereof Grant 10,342,798 - Gray , et al. July 9, 2	2019-07-09
Novel Pyrimidines As Egfr Inhibitors And Methods Of Treating Disorders App 20190194169 - GRAY; Nathanael S. ; et al.	2019-06-27
Imidazolyl kinase inhibitors and uses thereof Grant 10,287,268 - Gray , et al.	2019-05-14
Thiazolyl-containing Compounds For Treating Proliferative Diseases App 20190119301 - Gray; Nathanael S. ; et al.	2019-04-25
Pyrimidines as EGFR inhibitors and methods of treating disorders Grant 10,266,517 - Gray , et al.	2019-04-23
Uses of salt-inducible kinase (SIK) inhibitors Grant 10,265,321 - Shamji , et al.	2019-04-23
Degradation Of Cyclin-dependent Kinase 9 (cdk9) By Conjugation Of Cdk9 Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190111143 - GRAY; Nathanael S. ; et al.	2019-04-18
Degradation Of Cyclin-dependent Kinase 8 (cdk8) By Conjugation Of Cdk8 Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190112307 - GRAY; Nathanael S. ; et al.	2019-04-18
Pyrimido-diazepinon Kinase Scaffold Compounds And Methods For Treating P13k-mediated Disorders App 20190106424 - Gray; Nathanael S. ; et al.	2019-04-11
Degradation Of Cyclin-dependent Kinase 4/6 (cdk4/6) By Conjugation Of Cdk4/6 Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190092768 - GRAY; Nathanael S. ; et al.	2019-03-28
Small Molecule Myristate Inhibitors Of Bcr-abl And Methods Of Use App 20190084990 - Gray; Nathanael S. ; et al.	2019-03-21
Pyrimido-diazepinone Compounds And Methods Of Treating Disorders App 20190084998 - Gray; Nathanael S. ; et al.	2019-03-21
SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder Grant 10,233,157 - Cohen , et al.	2019-03-19
Inhibitors Of Cyclindependent Kinase 7 (cdk7) App 20190055248 - Gray; Nathanael S. ; et al.	2019-02-21
EGFR Inhibitors and Methods of Treating Disorders App 20190040065 - Gray; Nathanael S. ; et al.	2019-02-07
Pyrimido-diazepinone compounds and methods of treating disorders Grant 10,189,861 - Gray , et al. Ja	2019-01-29
Bifunctional Compounds For Her3 Degradation And Methods Of Use App 20190016703 - GRAY; Nathanael S. ; et al.	2019-01-17
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors App 20190015411 - Hammerman; Peter ; et al.	2019-01-17
Fused Bicyclic Pyrimidine Derivatives And Uses Thereof App 20180369243 - Gray; Nathanael S. ; et al.	2018-12-27
Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20180362545 - Gray; Nathanael S. ; et al.	2018-12-20
Inhibitors Of Cyclin-dependent Kinases App 20180362483 - Gray; Nathanael S. ; et al.	2018-12-20
Hydrophobically Tagged Small Molecules As Inducers Of Protein Degradation App 20180354954 - Gray; Nathanael S. ; et al.	2018-12-13
Substituted heterocyclic compounds for treating or preventing viral infections Grant 10,150,742 - Yang , et al. Dec	2018-12-11
4,6-pyrimidinylene Derivatives And Uses Thereof App 20180344733 - Gray; Nathanael S. ; et al.	2018-12-06
Inhibitors Of Cyclin-dependent Kinases App 20180319801 - Gray; Nathanael S. ; et al.	2018-11-08
Thiazolyl-containing compounds for treating proliferative diseases Grant 10,112,957 - Gray , et al. October 30, 2	2018-10-30
Inhibitors Of Egfr And Methods Of Use Thereof App 20180290975 - GRAY; Nathanael S. ; et al.	2018-10-11
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 10,081,639 - Gray , et al. September 25, 2	2018-09-25
Host Targeted Inhibitors Of Dengue Virus And Other Viruses App 20180265507 - Gray; Nathanael S. ; et al.	2018-09-20
Inhibitors Of Alk And Srpk And Methods Of Use App 20180258040 - HATCHER; John ; et al.	2018-09-13
Malt1 Inhibitors And Uses Thereof App 20180251489 - Gray; Nathanael S. ; et al.	2018-09-06
Lrrk2 Inhibitors And Methods Of Making And Using The Same App 20180244676 - GRAY; Nathanael S. ; et al.	2018-08-30
Sik Inhibitor For Use In A Method Of Treating An Inflammatory And/or Immune Disorder App 20180215719 - Cohen; Philip ; et al.	2018-08-02
Novel Pyrimidines As Egfr Inhibitors And Methods Of Treating Disorders App 20180194758 - GRAY; Nathanael S. ; et al.	2018-07-12
Methods To Treat Lymphoplasmacytic Lymphoma App 20180194739 - Treon; Steven P. ; et al.	2018-07-12
Janus kinase inhibitors and uses thereof Grant 10,017,477 - Gray , et al. July 10, 2	2018-07-10
Methods To Treat Lymphoplasmacytic Lymphoma App 20180186780 - Treon; Steven P. ; et al.	2018-07-05
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors App 20180169097 - Hammerman; Peter ; et al.	2018-06-21
Fused Bicyclic Pyrimidine Derivatives And Uses Thereof App 20180153894 - Gray; Nathanael S. ; et al.	2018-06-07
4,6-pyrimidinylene Derivatives And Uses Thereof App 20180110778 - Gray; Nathanael S. ; et al.	2018-04-26
Stk4 Inhibitors For Treatment Of Hematologic Malignancies App 20180111916 - GRAY; Nathanael S. ; et al.	2018-04-26
Hydrophobically Tagged Small Molecules As Inducers Of Protein Degradation App 20180093990 - Gray; Nathanael S. ; et al.	2018-04-05
Methods to treat lymphoplasmacytic lymphoma Grant 9,908,872 - Treon , et al. March 6, 2	2018-03-06
EGFR inhibitors and methods of treating disorders Grant 9,908,884 - Gray , et al. March 6, 2	2018-03-06
Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith Grant 9,879,028 - Gray , et al. January 30, 2	2018-01-30
Hydrophobically tagged janus kinase inhibitors and uses thereof Grant 9,862,688 - Gray , et al. January 9, 2	2018-01-09
Methods to treat lymphoplasmacytic lymphoma Grant 9,856,223 - Treon , et al. January 2, 2	2018-01-02
Novel Pyrimidines As Egfr Inhibitors And Methods Of Treating Disorders App 20170362204 - GRAY; Nathanael S. ; et al.	2017-12-21
Small Molecule Myristate Inhibitors Of Bcr-abl And Abl And Methods Of Use App 20170349595 - GRAY; Nathanael S. ; et al.	2017-12-07
Sik Inhibitor For Use In A Method Of Treating An Inflammatory And/or Immune Disorder App 20170342036 - Cohen; Philip ; et al.	2017-11-30
Hck As A Therapeutic Target In Myd88 Mutated Diseases App 20170333436 - Treon; Steven P. ; et al.	2017-11-23
Pyrimido-diazepinone Compounds And Methods Of Treating Disorders App 20170283422 - Gray; Nathanael S. ; et al.	2017-10-05
Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20170260208 - Gray; Nathanael S. ; et al.	2017-09-14
Thiazolyl-containing Compounds For Treating Proliferative Diseases App 20170233411 - Gray; Nathanael S. ; et al.	2017-08-17
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20170224700 - Shamji; Alykhan ; et al.	2017-08-10
Imidazolyl Kinase Inhibitors And Uses Thereof App 20170204082 - Gray; Nathanael S. ; et al.	2017-07-20
Macrocyclic Kinase Inhibitors And Uses Thereof App 20170204116 - Gray; Nathanael S. ; et al.	2017-07-20
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 9,701,683 - Gray , et al. July 11, 2	2017-07-11
Diazepane derivatives and uses thereof Grant 9,695,172 - Bradner , et al. July 4, 2	2017-07-04
Pyrimido-diazepinone compounds and methods of treating disorders Grant 9,676,792 - Gray , et al. June 13, 2	2017-06-13
Small molecule myristate inhibitors of Bcr-abl and methods of use Grant 9,670,214 - Gray , et al. June 6, 2	2017-06-06
Uses Of Kinase Inhibitors For Inducing And Maintaining Pluripotency App 20170114323 - Theunissen; Thorold W. ; et al.	2017-04-27
Hydrophobically Tagged Janus Kinase Inhibitors And Uses Thereof App 20170044112 - Gray; Nathanael S. ; et al.	2017-02-16
Janus Kinase Inhibitors And Uses Thereof App 20170044111 - Gray; Nathanael S. ; et al.	2017-02-16
Uses Of Diazepane Derivatives App 20170008895 - Bradner; James E. ; et al.	2017-01-12
Inhibitors Of C-jun-n-terminal Kinase (jnk) App 20160368910 - Gray; Nathanael S. ; et al.	2016-12-22
Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20160347755 - Gray; Nathanael S. ; et al.	2016-12-01
Diazepane Derivatives And Uses Thereof App 20160347749 - Bradner; James E. ; et al.	2016-12-01
Dihydropteridinone Derivatives And Uses Thereof App 20160347750 - Bradner; James E. ; et al.	2016-12-01
Methods To Treat Lymphoplasmacytic Lymphoma App 20160318878 - Treon; Steven P. ; et al.	2016-11-03
Methods To Treat Lymphoplasmacytic Lymphoma App 20160311807 - Treon; Steven P. ; et al.	2016-10-27
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 9,464,091 - Gray , et al. October 11, 2	2016-10-11
Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith App 20160137610 - Gray; Nathanael S. ; et al.	2016-05-19
Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20160122357 - Gray; Nathanael S. ; et al.	2016-05-05
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 9,266,890 - Gray , et al. February 23, 2	2016-02-23
Type Ii Raf Kinase Inhibitors App 20160046636 - Gray; Nathanael S. ; et al.	2016-02-18
Substituted Heterocyclic Compounds for Treating or Preventing Viral Infections App 20160031826 - Yang; Priscilla ; et al.	2016-02-04
Pyrimido-diazepinone Compounds And Methods Of Treating Disorders App 20160024115 - Gray; Nathanael S. ; et al.	2016-01-28
Type II Raf kinase inhibitors Grant 9,180,127 - Gray , et al. November 10, 2	2015-11-10
Small Molecule Myristate Inhibitors Of Bcr-abl And Methods Of Use App 20150094275 - GRAY; Nathanael S. ; et al.	2015-04-02
Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith App 20140011810 - Gray; Nathanael S. ; et al.	2014-01-09
Compounds and compositions as protein kinase inhibitors Grant 8,592,433 - Nagle , et al. November 26, 2	2013-11-26
Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith App 20130137709 - Gray; Nathanael S. ; et al.	2013-05-30
Type Ii Raf Kinase Inhibitors App 20130040949 - Gray; Nathanael S. ; et al.	2013-02-14
Egfr Inhibitors And Methods Of Treating Disorders App 20120094999 - Gray; Nathanael S. ; et al.	2012-04-19
Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20120040961 - Gray; Nathanael S. ; et al.	2012-02-16
Compounds and compositions as protein kinase inhibitors Grant 8,101,608 - Wan , et al. January 24, 2	2012-01-24
Small Molecule Myristate Inhibitors Of Bcr-abl And Methods Of Use App 20110312908 - Gray; Nathanael S. ; et al.	2011-12-22
Compounds That Modulate Egfr Activity And Methods For Treating Or Preventing Conditions Therewith App 20110207736 - GRAY; Nathanael S. ; et al.	2011-08-25
Compounds And Compositions Useful For The Treatment Of Malaria App 20110144107 - Chatterjee; Arnab K. ; et al.	2011-06-16
Immunosuppresant compounds and compositions Grant 7,939,519 - Pan , et al. May 10, 2	2011-05-10
Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity App 20110092491 - CHENG; Dai ; et al.	2011-04-21
Compositions And Methods For Treating Cancers App 20110021524 - Adrian; Francisco ; et al.	2011-01-27
Compounds and compositions as protein kinase inhibitors Grant 7,868,018 - Xie , et al. January 11, 2	2011-01-11
Compounds And Compositions As Protein Kinase Inhibitors App 20100324062 - Nagle; Advait ; et al.	2010-12-23
2-biphenylamino-4-aminopyrimidine Derivatives As Kinase Inhibitors App 20100298295 - Marsilje; Thomas H. ; et al.	2010-11-25
Compounds and compositions as protein kinase inhibitors Grant 7,713,958 - Wan , et al. May 11, 2	2010-05-11
Purine Compounds And Compositions As Kinase Inhibitors For The Treatment Of Plasmodium Related Diseases App 20100056494 - Winzeler; Elizabeth ; et al.	2010-03-04
Compositions And Methods For Fgf Receptor Kinases Inhibitors App 20090312321 - Ren; Pingda ; et al.	2009-12-17
Compounds And Compositions As Protein Kinase Inhibitors App 20090258910 - Gray; Nathanael S. ; et al.	2009-10-15
Compounds and compositions as protein kinase inhibitors Grant 7,589,101 - Okram , et al. September 15, 2	2009-09-15
Immunosuppressant Compounds and Compositions App 20090221547 - Gao; Wenqi ; et al.	2009-09-03
Compounds And Compositions As Protein Kinase Inhibitors App 20090181991 - Zhang; Qiong ; et al.	2009-07-16
Compounds and Compositions as Protein Kinase Inhibitors App 20090137555 - Wan; Yongqin ; et al.	2009-05-28
Compounds And Compositions As Protein Kinase Inhibitors App 20090069327 - Ding; Qiang ; et al.	2009-03-12
Immunosuppresant Compounds And Compositions App 20090036423 - Pan; Shifeng ; et al.	2009-02-05
Immunosuppressant compounds and compositions Grant 7,462,629 - Pan , et al. December 9, 2	2008-12-09
Compounds and Compositions as Protein Kinase Inhibitors App 20080300246 - Xie; Yongping ; et al.	2008-12-04
Compounds and Compositions as Protein Kinase Inhibitors App 20080300267 - Okram; Barun ; et al.	2008-12-04
Compounds and Compositions as Protein Kinase Inhibitors App 20080287432 - Okram; Barun ; et al.	2008-11-20
Compounds and compositions as protein kinase inhibitors Grant 7,449,582 - Ding , et al. November 11, 2	2008-11-11
5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors App 20080227783 - Wan; Yongqin ; et al.	2008-09-18
Compounds and Compositions as Protein Kinase Inhibitors App 20080221192 - Wan; Yongqin ; et al.	2008-09-11
Compositions And Methods For Inducing Osteogenesis App 20080214541 - Wu; Xu ; et al.	2008-09-04
Compounds And Compositions As Protein Kinase Inhibitors App 20080108616 - Ding; Qiang ; et al.	2008-05-08
Compositions and methods for inducing osteogenesis Grant 7,273,864 - Wu , et al. September 25, 2	2007-09-25
Kinase Inhibitor Scaffolds And Methods For Their Preparation App 20070191380 - Ding; Sheng ; et al.	2007-08-16
Bicyclic compounds and compositions Grant 7,256,206 - Pan , et al. August 14, 2	2007-08-14
6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells Grant 7,253,166 - Ding , et al. August 7, 2	2007-08-07
Kinase inhibitor scaffolds and methods for their preparation Grant 7,176,312 - Ding , et al. February 13, 2	2007-02-13
Bis-aromatic alkanols Grant 7,169,817 - Pan , et al. January 30, 2	2007-01-30
Cyclic compounds and compositions as protein kinase inhibitors Grant 7,151,096 - Ren , et al. December 19, 2	2006-12-19
Immunosuppressant compounds and compositions Grant 7,060,697 - Marsilje , et al. June 13, 2	2006-06-13
Methods for the synthesis of substituted purines App 20060009642 - Ding; Sheng ; et al.	2006-01-12
Methods for the synthesis of substituted purines Grant 6,949,644 - Ding , et al. September 27, 2	2005-09-27
Compounds and compositions as protein kinase inhibitors App 20050209285 - Gray, Nathanael S. ; et al.	2005-09-22
Compounds and compositions as protein kinase inhibitors App 20050187230 - Ding, Qiang ; et al.	2005-08-25
Purine inhibitors of protein kinases, G proteins and polymerases Grant 6,803,371 - Gray , et al. October 12, 2	2004-10-12
Purine inhibitors of protein kinases, G proteins and polymerases Grant 6,617,331 - Gray , et al. September 9, 2	2003-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.